Moomoo AI 已提取核心訊息
On February 9, 2024, Canopy Growth Corporation, a leading North American cannabis and consumer packaged goods company, reported its financial results for the third quarter of the fiscal year 2024, which ended on December 31, 2023. The company announced a 9% year-over-year increase in Canada adult-use cannabis business-to-business net revenue and an 11% increase in Canada medical cannabis net revenue. Canopy Growth achieved a consolidated gross margin of 36% for the quarter, marking a significant improvement from the previous year's negative margins. The company also reported a 54% sequential increase in net revenue for Storz & Bickel, driven by strong sales of the new VENTY portable vaporizer. Despite a 7% year-over-year decline in consolidated net revenue, which totaled $79 million, the company saw an...Show More
On February 9, 2024, Canopy Growth Corporation, a leading North American cannabis and consumer packaged goods company, reported its financial results for the third quarter of the fiscal year 2024, which ended on December 31, 2023. The company announced a 9% year-over-year increase in Canada adult-use cannabis business-to-business net revenue and an 11% increase in Canada medical cannabis net revenue. Canopy Growth achieved a consolidated gross margin of 36% for the quarter, marking a significant improvement from the previous year's negative margins. The company also reported a 54% sequential increase in net revenue for Storz & Bickel, driven by strong sales of the new VENTY portable vaporizer. Despite a 7% year-over-year decline in consolidated net revenue, which totaled $79 million, the company saw an 81% increase in Rest-of-World cannabis revenue, attributed to growth in Australia and Europe. Canopy Growth's free cash flow from continuing operations improved by 57% year-over-year, and the company reduced its overall debt by $69 million during the quarter. Management reaffirmed its expectation to achieve positive Adjusted EBITDA in each business unit by the end of FY2024. Additionally, Canopy Growth is moving forward with its Canopy USA strategy, with a special shareholder meeting scheduled for April 12, 2024, to discuss the creation of a new class of exchangeable shares, which would provide investors with exposure to the U.S. cannabis market.
2024年2月9日，北美領先的大麻和消費品包裝公司Canopy Growth Corporation公佈了截至2023年12月31日的2024財年第三季度的財務業績。該公司宣佈，加拿大成人用大麻企業對企業淨收入同比增長9％，加拿大醫用大麻淨收入增長11％。Canopy Growth在本季度實現了36％的合併毛利率，與去年的負利潤率相比有了顯著改善。該公司還報告稱，受新款VENTY便攜式蒸發器的強勁銷售推動，Storz & Bickel的淨收入連續增長54％。儘管合併淨收入同比下降7％，總額爲7,900萬美元，但由於澳大利亞和歐洲的增長，該公司的世界其他地區大麻收入增長了81％。Canopy G...展開全部
2024年2月9日，北美領先的大麻和消費品包裝公司Canopy Growth Corporation公佈了截至2023年12月31日的2024財年第三季度的財務業績。該公司宣佈，加拿大成人用大麻企業對企業淨收入同比增長9％，加拿大醫用大麻淨收入增長11％。Canopy Growth在本季度實現了36％的合併毛利率，與去年的負利潤率相比有了顯著改善。該公司還報告稱，受新款VENTY便攜式蒸發器的強勁銷售推動，Storz & Bickel的淨收入連續增長54％。儘管合併淨收入同比下降7％，總額爲7,900萬美元，但由於澳大利亞和歐洲的增長，該公司的世界其他地區大麻收入增長了81％。Canopy Growth來自持續經營業務的自由現金流同比增長了57％，該公司在本季度的總債務減少了6900萬美元。管理層重申，預計在 FY2024 結束之前，每個業務部門的調整後息稅折舊攤銷前利潤將實現正數。此外，Canopy Growth正在推進其Canopy USA戰略，計劃於2024年4月12日舉行特別股東會議，討論創建新的可交換股票類別的問題，這將爲投資者提供進入美國大麻市場的機會。
有用
沒用